Cold & Cough Remedies - Southern Africa

  • Southern Africa
  • In Southern Africa, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$233.30m.
  • It is projected that the market will experience an annual growth rate of 4.78% from 2024 to 2029 (CAGR 2024-2029).
  • Comparing globally, the in the United States leads the market with a revenue of US$11,190.00m in 2024.
  • When considering the population, it can be observed that per person revenues of US$3.33 are generated in 2024.
  • Southern Africa's cold and cough remedies market is experiencing a surge in demand for herbal and natural remedies.

Key regions: Australia, Japan, India, Brazil, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Southern Africa is experiencing steady growth and development due to several factors.

Customer preferences:
Customers in Southern Africa are increasingly seeking over-the-counter remedies for cold and cough symptoms. This is driven by a growing awareness and preference for self-medication, as well as the convenience and accessibility of these products. Additionally, customers are looking for remedies that provide quick relief and are effective in alleviating symptoms such as congestion, sore throat, and cough.

Trends in the market:
One major trend in the Cold & Cough Remedies market in Southern Africa is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the ingredients in the products they use and prefer natural alternatives to synthetic drugs. This trend is driven by a desire for safer and more sustainable options, as well as a belief in the efficacy of traditional remedies.Another trend in the market is the rise of combination remedies that offer relief for multiple symptoms. Customers are looking for products that can address their various cold and cough symptoms in a single dose, saving them time and money. Combination remedies that include ingredients such as antihistamines, decongestants, and cough suppressants are particularly popular.

Local special circumstances:
Southern Africa has a high prevalence of respiratory infections, which contributes to the demand for cold and cough remedies. Factors such as the region's climate, air pollution, and lifestyle habits can increase the risk of respiratory illnesses. As a result, customers in Southern Africa are more likely to seek remedies for cold and cough symptoms.In addition, cultural beliefs and practices also play a role in shaping customer preferences in the region. Traditional medicine and herbal remedies are deeply rooted in the culture of many Southern African countries. Customers may prefer remedies that align with their cultural beliefs and practices, leading to a demand for products that incorporate traditional ingredients.

Underlying macroeconomic factors:
The growing middle class in Southern Africa is driving the demand for Cold & Cough Remedies. As disposable incomes increase, customers have more purchasing power and are willing to spend on healthcare products. This has created a larger consumer base for cold and cough remedies, contributing to market growth.Furthermore, urbanization and changing lifestyles are also influencing the market. Urban areas in Southern Africa are experiencing rapid growth, leading to increased exposure to air pollution and higher stress levels. These factors can weaken the immune system and make individuals more susceptible to respiratory infections. As a result, the demand for cold and cough remedies is expected to continue growing in urban areas.In conclusion, the Cold & Cough Remedies market in Southern Africa is developing due to customer preferences for over-the-counter remedies, the demand for natural and combination remedies, the region's high prevalence of respiratory infections, cultural beliefs and practices, the growing middle class, and urbanization. These factors are driving market growth and shaping the trends in the industry.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)